30019111000001101: Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual medicinal product\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Cyproterone\Product containing only cyproterone in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Cyproterone\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing cyproterone\Cyproterone\Product containing only cyproterone in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing cyproterone\Cyproterone\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing cyproterone\Product containing cyproterone in oral dose form (medicinal product form)\Product containing only cyproterone in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing cyproterone\Cyproterone\Product containing only cyproterone in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing cyproterone\Cyproterone\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing cyproterone\Product containing cyproterone in oral dose form (medicinal product form)\Product containing only cyproterone in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing cyproterone\Cyproterone\Product containing only cyproterone in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing cyproterone\Cyproterone\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing cyproterone\Product containing cyproterone in oral dose form (medicinal product form)\Product containing only cyproterone in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Cyproterone\Product containing only cyproterone in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Cyproterone\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing cyproterone in oral dose form (medicinal product form)\Product containing only cyproterone in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet\Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

93685501000001110 Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

93685601000001114 Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Product containing precisely cyproterone acetate 50 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	Has active ingredient	Cyproterone acetate	false	Inferred relationship	Existential restriction modifier
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	Cyproterone acetate	true	Inferred relationship	Existential restriction modifier
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd) 168 tablet	Has AMP	True	Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
93685501000001110	Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
93685601000001114	Cyproterone 50mg tablets (Mawdsley-Brooks & Company Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module